ContributorsPublishersAdvertisers

Strategies That Combine Immunotherapies With Bevacizumab, Other Agents May Expand Utility of Immunotherapy in Recurrent Ovarian Cancer

oncnursingnews.com
 2021-10-10

Cover picture for the articleCombining immunotherapy with other targeted therapies may result in more promising outcomes than immunotherapy alone in the treatment of recurrent ovarian cancer, according to an expert at University of California, Los Angeles. Although single-agent checkpoint inhibitors have not induced superior outcomes in patients with ovarian cancer, combining those agents...

www.oncnursingnews.com

Comments / 0

Comments / 0